MedPath

Prevalence and the relationship between vitamin D deficiency and inflammatory markers among adult outpatients with depressio

Conditions
vitamin D deficiency in adult outpatients with depression.
Vitamin D deficiency, depression, prevalence, inflammatory marker
Registration Number
TCTR20221231006
Lead Sponsor
Quality Improvement Fund, King Chulalongkorn Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Enrolling by invitation
Sex
All
Target Recruitment
80
Inclusion Criteria

1. Aged 18-60 years old
2. Depressive disorder was diagnosed base on DSM-5 criteria

Exclusion Criteria

1.CKD stage III-V
2.Primary hyperparathyroidism
3.Granulomatous disease
4.GI malabsorption: short bowel syndrome, pancreatitis, IBD, bariatric surgery
5.Liver disease
6.Renal insufficiency or nephrotic syndrome
7.Medication history which affects vitamin D levels in one year
- Antineoplastic drugs: cyclophosphamide, taxol, tamoxifen
- Antibiotic and antifungal: clotrimazole, rifampicin
- Anti-inflammatory agents: dexamethasone
- Anti-hypertensive drug: nifedipine, spironolactone
- Antiretroviral drugs: Ritonavir
- Endocrine drugs: Cyproterone acetate
8. Pregnancy and lactation
9. Vitamin D supplement

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Vitamin D deficiency The time point in which depression severity was assessed 25(OH)D measured by CLIA
Secondary Outcome Measures
NameTimeMethod
Relationship between vitamin D deficiency and inflammatory marker The time point in which depression severity was assessed Blood for CRP and relationship was measured by Logistic Regression (Odds Ratio) by SPSS
© Copyright 2025. All Rights Reserved by MedPath